“Deep Brain Stimulation Market is valued at USD 836.87 Million in 2018 and expected to reach USD 1481.39 Million by 2025 with the CAGE of 8.50% over the forecast period.”
The Deep Brain Stimulation Market research report provides a succinct analysis on the recent market trends. In addition, the report offers a thorough abstract on the statistics, market estimates and revenue forecasts, which further highlights its position in the industry, in tandem with the growth strategies adopted by leading industry players.
Get Sample Copy of This Premium Report @ https://brandessenceresearch.com/requestSample/PostId/289
*The sample pages of this report is immediately accessible on-demand.**
Market Analysis of Deep Brain Stimulation –
In deep brain stimulation, electrodes are placed in a specific area of the brain depending on the symptoms being treated. Generally, the electrodes are placed on both the left and right sides of the brain through small holes made at the top of the skull. The electrodes are connected by long wires that travel under the skin and down the neck to a battery-powered stimulator under the skin of the chest. When turned on, the stimulator sends electrical pulses to block the faulty nerve signals causing tremors, rigidity, and other symptoms. The deep brain stimulation (DBS) is a surgery to implant a device that sends electrical signals to brain areas responsible for body movement. This Electrode are placed with deep in the brain and are connected to a stimulator device related to heart pacemaker. Hence, the deep brain stimulation system has three parts that are implanted inside the body such as Neurostimulator, Lead and Extension.
Key Players for Global Deep Brain Stimulation Market Reports-
Some major key players for global deep brain stimulation market are Boston Scientific Corporation (BSX), Medtronic plc. (MDT), St. Jude Medical, Inc. (STJ), Aleva Neurotherapeutics SA, Beijing Pins Medical Co., Ltd., NeuroPace, Inc., NeuroSigma Inc (NSIG) and others.
Global Deep Brain Stimulation Market Dynamics –
The rapidly increase in prevalence of Parkinson’s disease coupled with innovation in treatment such as integration of physiological imaging and highly sensitive structural imaging with deep brain stimulation (DBS) can also be recognized to the market growth. Hence, the increasing geriatric population on the rise, awareness about neurological diseases among patients, and preference by healthcare professionals are anticipated to trigger the sector development. The healthcare professionals believe that single channel offers more programming options to the neurologists, which led to increased preference for single channel deep brain stimulation device. According to the World Health Organization (WHO), the prominence of pain related diseases causes disability and the global burden of chronic pain was estimated at 1.9 billion due to global population is now living longer with consequences of chronic disease and injuries is rapidly increasing which is responsible for the growth of deep brain stimulation market during the forecast period. The advantages such as minimal pain, high cost-efficiency, safety, efficacy, and rapid recovery are also leading to the increased demand of deep brain stimulation. Factors responsible for replacing open/invasive surgeries with minimally invasive surgeries are lesser incision wounds, higher patient satisfaction, reduced hospital stay, postsurgical complications, and mortality rate, due to which, the clinical use of deep brain stimulation (DBS) is among the most important advancements in the clinical neurosciences in the past two decades. However, the development of deep brain stimulation (DBS) has opened new opportunity to access and interrogate malfunctioning brain circuits and to test the therapeutic potential of regulating the output of these circuits in a broad range of disorders. Additionally, the deep brain stimulation science will help to define the future role of this technology in the development of novel therapeutics for the most challenging disorders affecting the human brain.
Global Deep Brain Stimulation Market Regional Analysis –
North America is dominating the deep brain stimulation market due to the highest market share in terms of profits in overall market of Deep Brain Stimulation across the globe. However, the availability of other treatment options such as drug therapies and surgeries restrict the growth of the deep brain stimulation devices market. The North America performance like pacemaker for the brain, DBS uses electrodes implanted in the brain to send out electrical impulses to different areas in the brain linked to disorders. According to the World Health Organization (WHO), the communicable neurological disorder is the main cause of increasing demand for the deep brain stimulation devices as the number of deaths due to this disorder has been tremendously rose by 36.7 from 1990 to 2015 which include alzheimer disease cases from 40.2 million to 52.7 million, the prevalent tension type headaches has rose to 1681.6 from 1337.3 million comprising 16.8% of global deaths. The increasing awareness regarding the application of deep brain stimulation device contributes its larger share in this region. Furthermore, the Asia-Pacific region provides significant opportunities for the growth of this market cited to many technological advancements and healthcare reforms in the region. However, emerging economies like India and China with their growing disposable income and advanced technological awareness enabling them to enter into this market and contribute towards its growth of the market.
Key Benefits for Global Deep Brain Stimulation Market Report–
Global Deep Brain Stimulation Market report covers in depth historical and forecast analysis.
Global Deep Brain Stimulation Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
Global Deep Brain Stimulation Market report helps to identify opportunities in market place.
Global Deep Brain Stimulation Market report covers extensive analysis of emerging trends and competitive landscape.
Global Deep Brain Stimulation Market Segmentation
By Type – Sub thalamic DBS, Globus Pallidus DBS, Thalamic DBS, Pedunculopontine Nucleus DBS
By Product – Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator
By Application – Parkinson’s Disease (PD), Epilepsy, Dystonia, Obsessive Compulsive Disorder (OCD), Others
By End-User – Hospitals, Ambulatory Surgical Centers, Neurological Centers, Others
By Regional & Country Analysis
North America, US, Mexico, Chily, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, South Korea, Japan, India, Southeast Asia, Latin America, Brazil, The Middle East and Africa, GCC, Africa, Rest of Middle East and Africa
Get Full information of This Report@ https://brandessenceresearch.com/healthcare/medical-devices/global-deep-brain-stimulating-market-2018-2024
About Us: Brandessence Market Research and Consulting Pvt. ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at: firstname.lastname@example.org